 Ashim Bagchi
Concepts (184)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 10 | 2024 | 137 | 1.430 |
Why?
| | Interleukin-10 | 4 | 2020 | 106 | 1.390 |
Why?
| | Myocardial Reperfusion Injury | 2 | 2020 | 49 | 1.300 |
Why?
| | Doxorubicin | 6 | 2024 | 259 | 1.190 |
Why?
| | Oxidative Stress | 14 | 2024 | 958 | 1.120 |
Why?
| | Toll-Like Receptor 4 | 2 | 2017 | 51 | 1.020 |
Why?
| | Shigella dysenteriae | 3 | 2010 | 3 | 0.990 |
Why?
| | Bacterial Outer Membrane Proteins | 3 | 2010 | 32 | 0.970 |
Why?
| | Apoptosis | 10 | 2024 | 1302 | 0.920 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2024 | 42 | 0.840 |
Why?
| | Toll-Like Receptor 2 | 2 | 2020 | 29 | 0.790 |
Why?
| | Phospholipid Ethers | 1 | 2020 | 2 | 0.770 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 33 | 0.760 |
Why?
| | Dysentery, Bacillary | 2 | 2010 | 4 | 0.730 |
Why?
| | Myocardium | 3 | 2022 | 443 | 0.690 |
Why?
| | Lipid Metabolism | 1 | 2020 | 194 | 0.680 |
Why?
| | Heart Failure | 5 | 2022 | 541 | 0.650 |
Why?
| | Ascorbic Acid | 4 | 2020 | 33 | 0.590 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 40 | 0.590 |
Why?
| | Rats | 13 | 2024 | 3419 | 0.560 |
Why?
| | Cardiomyopathies | 4 | 2024 | 131 | 0.560 |
Why?
| | Antioxidants | 5 | 2021 | 297 | 0.520 |
Why?
| | Rats, Sprague-Dawley | 9 | 2024 | 1664 | 0.510 |
Why?
| | Cytokines | 4 | 2017 | 677 | 0.500 |
Why?
| | Animals | 20 | 2024 | 14409 | 0.450 |
Why?
| | Apoptosis Regulatory Proteins | 4 | 2021 | 96 | 0.390 |
Why?
| | Adaptive Immunity | 1 | 2009 | 39 | 0.350 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2010 | 116 | 0.340 |
Why?
| | Antibodies | 1 | 2009 | 178 | 0.340 |
Why?
| | Scavenger Receptors, Class E | 2 | 2022 | 217 | 0.340 |
Why?
| | Cells, Cultured | 6 | 2017 | 1737 | 0.330 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2022 | 435 | 0.320 |
Why?
| | Cell Survival | 4 | 2020 | 657 | 0.300 |
Why?
| | Myocardial Infarction | 2 | 2022 | 423 | 0.290 |
Why?
| | Caspase 3 | 4 | 2019 | 135 | 0.270 |
Why?
| | Reactive Oxygen Species | 4 | 2021 | 491 | 0.260 |
Why?
| | Major Histocompatibility Complex | 1 | 2004 | 14 | 0.250 |
Why?
| | Phosphorylation | 3 | 2017 | 613 | 0.250 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 44 | 0.250 |
Why?
| | Glucosides | 1 | 2024 | 16 | 0.250 |
Why?
| | Cardiotonic Agents | 2 | 2017 | 95 | 0.240 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 476 | 0.240 |
Why?
| | Male | 12 | 2021 | 27347 | 0.230 |
Why?
| | Lymphatic Vessels | 1 | 2024 | 49 | 0.230 |
Why?
| | Lymphocyte Activation | 3 | 2010 | 197 | 0.230 |
Why?
| | Benzhydryl Compounds | 1 | 2024 | 75 | 0.230 |
Why?
| | Rats, Wistar | 2 | 2021 | 237 | 0.230 |
Why?
| | Signal Transduction | 5 | 2022 | 1752 | 0.220 |
Why?
| | Disease Models, Animal | 2 | 2020 | 1647 | 0.220 |
Why?
| | Lovastatin | 1 | 2021 | 8 | 0.210 |
Why?
| | Probucol | 1 | 2021 | 4 | 0.210 |
Why?
| | T-Lymphocytes | 1 | 2004 | 374 | 0.210 |
Why?
| | Calcium | 1 | 2024 | 434 | 0.200 |
Why?
| | Anticholesteremic Agents | 1 | 2021 | 34 | 0.200 |
Why?
| | Transcription Factor CHOP | 1 | 2021 | 9 | 0.200 |
Why?
| | Activating Transcription Factor 6 | 1 | 2021 | 12 | 0.200 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 132 | 0.200 |
Why?
| | Endoplasmic Reticulum | 1 | 2021 | 123 | 0.190 |
Why?
| | Ventricular Function, Left | 2 | 2022 | 182 | 0.180 |
Why?
| | Nitric Oxide Synthase | 2 | 2017 | 102 | 0.180 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 126 | 0.180 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2017 | 85 | 0.180 |
Why?
| | Inflammation Mediators | 2 | 2017 | 128 | 0.180 |
Why?
| | Cytoprotection | 1 | 2019 | 48 | 0.180 |
Why?
| | Atherosclerosis | 1 | 2022 | 249 | 0.170 |
Why?
| | Immunoglobulin G | 2 | 2010 | 227 | 0.170 |
Why?
| | Hydrogen | 1 | 2018 | 13 | 0.170 |
Why?
| | Free Radical Scavengers | 1 | 2018 | 35 | 0.170 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 383 | 0.170 |
Why?
| | Heart | 1 | 2021 | 361 | 0.170 |
Why?
| | Immunity, Innate | 1 | 2018 | 114 | 0.160 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 11 | 0.150 |
Why?
| | T-Lymphocyte Subsets | 2 | 2009 | 41 | 0.150 |
Why?
| | Mice, Knockout | 2 | 2017 | 927 | 0.150 |
Why?
| | Fructose | 1 | 2017 | 29 | 0.150 |
Why?
| | Adventitia | 1 | 2016 | 5 | 0.150 |
Why?
| | Plant Extracts | 1 | 2019 | 193 | 0.150 |
Why?
| | Mitochondria | 1 | 2021 | 490 | 0.150 |
Why?
| | Radiation Injuries | 1 | 2018 | 153 | 0.150 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2016 | 40 | 0.140 |
Why?
| | RNA Interference | 1 | 2017 | 195 | 0.140 |
Why?
| | Mice, Inbred BALB C | 2 | 2010 | 370 | 0.140 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 1551 | 0.140 |
Why?
| | Fibrosis | 1 | 2017 | 209 | 0.140 |
Why?
| | Transfection | 1 | 2017 | 399 | 0.140 |
Why?
| | Stress, Physiological | 1 | 2017 | 194 | 0.140 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 142 | 0.140 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2016 | 140 | 0.140 |
Why?
| | Genotype | 1 | 2017 | 600 | 0.130 |
Why?
| | Stem Cells | 1 | 2016 | 194 | 0.130 |
Why?
| | Nitric Oxide | 1 | 2017 | 298 | 0.120 |
Why?
| | Phenotype | 1 | 2017 | 819 | 0.120 |
Why?
| | Insulin | 1 | 2016 | 511 | 0.110 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2012 | 10 | 0.110 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 31 | 0.110 |
Why?
| | I-kappa B Kinase | 1 | 2012 | 29 | 0.110 |
Why?
| | Oleic Acid | 1 | 2012 | 7 | 0.110 |
Why?
| | Transcription Factor RelA | 1 | 2012 | 30 | 0.110 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2012 | 43 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2012 | 73 | 0.110 |
Why?
| | bcl-X Protein | 1 | 2012 | 61 | 0.110 |
Why?
| | Inflammation | 1 | 2017 | 678 | 0.110 |
Why?
| | Interleukin-1beta | 1 | 2012 | 92 | 0.110 |
Why?
| | Protein Transport | 1 | 2012 | 195 | 0.110 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 2001 | 0.100 |
Why?
| | STAT3 Transcription Factor | 1 | 2011 | 88 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2011 | 176 | 0.100 |
Why?
| | Neoplasms | 1 | 2021 | 1322 | 0.090 |
Why?
| | Clonal Deletion | 1 | 2010 | 1 | 0.090 |
Why?
| | Immunity, Mucosal | 1 | 2010 | 20 | 0.090 |
Why?
| | Caspase 1 | 1 | 2010 | 28 | 0.090 |
Why?
| | HLA-DR Antigens | 1 | 2009 | 15 | 0.090 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 12 | 0.090 |
Why?
| | Immunoglobulin A | 1 | 2010 | 54 | 0.090 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2009 | 75 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2016 | 486 | 0.090 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2009 | 46 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2009 | 50 | 0.090 |
Why?
| | Immunization | 1 | 2010 | 95 | 0.090 |
Why?
| | Humans | 8 | 2022 | 54391 | 0.090 |
Why?
| | Mice | 3 | 2016 | 6428 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2012 | 1203 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 181 | 0.080 |
Why?
| | Reactive Nitrogen Species | 2 | 2017 | 37 | 0.080 |
Why?
| | Molecular Weight | 1 | 2004 | 100 | 0.060 |
Why?
| | Interleukin-4 | 1 | 2004 | 48 | 0.060 |
Why?
| | Interleukin-2 | 1 | 2004 | 75 | 0.060 |
Why?
| | Superoxides | 1 | 2004 | 61 | 0.060 |
Why?
| | Lymph | 1 | 2024 | 21 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2004 | 176 | 0.060 |
Why?
| | Muscle Contraction | 1 | 2024 | 111 | 0.060 |
Why?
| | Antigens, CD | 1 | 2004 | 242 | 0.060 |
Why?
| | Corn Oil | 1 | 2022 | 13 | 0.050 |
Why?
| | Female | 2 | 2021 | 28471 | 0.050 |
Why?
| | Creatine Kinase | 2 | 2012 | 37 | 0.050 |
Why?
| | Monocrotaline | 1 | 2021 | 7 | 0.050 |
Why?
| | Ventricular Remodeling | 1 | 2022 | 65 | 0.050 |
Why?
| | Glutathione Peroxidase | 1 | 2021 | 28 | 0.050 |
Why?
| | Catalase | 1 | 2021 | 74 | 0.050 |
Why?
| | Ligands | 1 | 2022 | 229 | 0.050 |
Why?
| | Stroke Volume | 1 | 2022 | 151 | 0.050 |
Why?
| | Macrophages | 1 | 2004 | 404 | 0.050 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2021 | 32 | 0.050 |
Why?
| | Superoxide Dismutase | 1 | 2021 | 125 | 0.050 |
Why?
| | Organ Size | 1 | 2021 | 237 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 1476 | 0.050 |
Why?
| | NF-kappa B | 1 | 2022 | 336 | 0.050 |
Why?
| | Hemodynamics | 1 | 2021 | 291 | 0.050 |
Why?
| | Caspase 7 | 1 | 2019 | 11 | 0.040 |
Why?
| | Hydroxyl Radical | 1 | 2018 | 10 | 0.040 |
Why?
| | Echocardiography | 1 | 2021 | 392 | 0.040 |
Why?
| | Lung | 1 | 2021 | 508 | 0.040 |
Why?
| | Phenols | 1 | 2019 | 122 | 0.040 |
Why?
| | Adolescent | 1 | 2009 | 6900 | 0.040 |
Why?
| | Risk Factors | 2 | 2017 | 3937 | 0.040 |
Why?
| | Hyperuricemia | 1 | 2017 | 7 | 0.040 |
Why?
| | Uric Acid | 1 | 2017 | 32 | 0.040 |
Why?
| | Child | 1 | 2009 | 7368 | 0.040 |
Why?
| | Risk Reduction Behavior | 1 | 2017 | 69 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2017 | 223 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 92 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 1152 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 206 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 736 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 290 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2016 | 658 | 0.030 |
Why?
| | Blood Pressure | 1 | 2017 | 587 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2016 | 720 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2016 | 300 | 0.030 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 2011 | 2 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 142 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2012 | 203 | 0.030 |
Why?
| | Permeability | 1 | 2011 | 87 | 0.030 |
Why?
| | Hypertension | 1 | 2017 | 565 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 141 | 0.030 |
Why?
| | Prognosis | 1 | 2017 | 2126 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 99 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2011 | 328 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 684 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 251 | 0.020 |
Why?
| | Heart Diseases | 1 | 2012 | 239 | 0.020 |
Why?
| | Up-Regulation | 1 | 2011 | 509 | 0.020 |
Why?
| | Pregnancy | 1 | 2016 | 2639 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 547 | 0.020 |
Why?
|
|
Bagchi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|